US · Healthcare

Shield Therapeutics plc (SHIEF)

Drug Manufacturers - Specialty & Generic

Shield Therapeutics plc (SHIEF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for SHIEF

P/E ratio

18.00

Shield Therapeutics plc (SHIEF) — FAQ

What is SHIEF's P/E ratio?

The price-to-earnings (P/E) ratio for Shield Therapeutics plc (SHIEF) is 18.00 (data as of 2026-05-23).

Does Shield Therapeutics plc pay a dividend?

Dividend yield is not available in the current snapshot for Shield Therapeutics plc (SHIEF). Check the MyAverix Finance app for the latest dividend data.

What sector is Shield Therapeutics plc in?

Shield Therapeutics plc (SHIEF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is SHIEF listed on?

SHIEF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)